However, the study is still looking for women who meet the criteria for the high-risk part of the study.
The high-risk criteria are:
19 years or older
pregnant with a singleton
between 10 weeks and 23 weeks 6 days gestation
qualifies for invasive procedures (amniocentesis/ CVS) whether you choose them or not (applicable invasive procedure eligibility is: screen positive for trisomy 21, 18; maternal age 40 years or older; a previous trisomy pregnancy; or pregnancy with IVF with ICSI)
If you meet the above criteria and would like to donate a blood sample to help validate NIPT technology in Canada, please contact the study coordinator at email@example.com
Please note that study participants do not receive any results.